KalVista Pharmaceuticals (KALV) Assets (2016 - 2024)
Historic Assets for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $294.8 million.
- KalVista Pharmaceuticals' Assets changed N/A to $294.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $294.8 million, marking a year-over-year change of. This contributed to the annual value of $235.4 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Assets is $294.8 million.
- Over the past 5 years, KalVista Pharmaceuticals' Assets peaked at $294.8 million during Q4 2024, and registered a low of $66.2 million during Q1 2021.
- For the 4-year period, KalVista Pharmaceuticals' Assets averaged around $143.8 million, with its median value being $126.4 million (2023).
- Per our database at Business Quant, KalVista Pharmaceuticals' Assets plummeted by 3568.17% in 2021 and then surged by 2486.47% in 2024.
- KalVista Pharmaceuticals' Assets (Quarter) stood at $75.4 million in 2020, then dropped by 12.25% to $66.2 million in 2021, then surged by 109.56% to $138.7 million in 2023, then skyrocketed by 112.49% to $294.8 million in 2024.
- Its last three reported values are $294.8 million in Q4 2024, $160.8 million for Q4 2024, and $200.2 million during Q3 2024.